JAMA analysis stirs debate

Share this article:
A JAMA analysis questioning the effectiveness of antidepressants has renewed debate.

The meta-analysis found that antidepressents are useful for those with severe depression symptoms but don't work any better than placebo in mild cases. In a letter to The New York Times, Weill Cornell psychiatry professor Dr. Richard Friedman derided the research for including only two drugs and for excluding studies that screened out placebo responders.

Two of the researchers defended their methodology, saying many approved antidepressants vary little in effectiveness and that their aim was to estimate effects of medications vs. placebos.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.